Hepatitis B Diagnostic Tests Market Size, Share Report, Analysis, Trends, Growth 2032

What is the Hepatitis B Diagnostic Tests Market Size?

The global Hepatitis B Diagnostic Tests market size accrued earnings worth approximately USD 1647.58 Million in 2023 and is predicted to gain revenue of about USD 2,021.75 Million by 2032, is set to record a CAGR of nearly 2.30% over the period from 2024 to 2032.

Request Free SampleRequest Free Sample

Key Insights

• As per the analysis shared by our research analyst, the hepatitis b diagnostic tests market is anticipated to grow at a CAGR of 2.30% during the forecast period.
• The global hepatitis b diagnostic tests market was estimated to be worth approximately USD 1647.58 million in 2023 and is projected to reach a value of USD 2,021.75 million by 2032.
• The growth of the hepatitis b diagnostic tests market is being driven by the increasing prevalence of hepatitis B virus (HBV) infections worldwide and the rising need for early detection and monitoring.
• Based on the product type, the enzyme immunoassay kits segment is growing at a high rate and is projected to dominate the market.
• On the basis of end-user, the hospitals segment is projected to swipe the largest market share.
• By region, North America is expected to dominate the global market during the forecast period.

Hepatitis B Diagnostic Tests Market Overview

The liver is an essential organ which filters blood, processes nutrients, and fights against infection. The inflammation of the liver is termed as Hepatitis. The inflammation of the liver affects its normal functionality. The infection is usually caused by a virus. Hepatitis B is a serious liver disease which is caused due to infection. Acute and chronic are two type of hepatitis B based on the severity of the disease. Acute Hepatitis B is a short-term infection which occurs within 6 months after somebody is tainted with the virus. Lifelong infection with the Hepatitis B virus is categorized under chronic hepatitis. Hepatitis B is a life-threatening infection and has become the main healthcare problem globally. The growing prevalence of the disease is developing an increased requirement for fast and early diagnosis; this is expected to propel the growth of hepatitis B diagnostic tests market over the forecast period.

In order to give the users of this report a comprehensive view of the hepatitis B diagnostic tests market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein the product type and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.

Request Free SampleRequest Free Sample

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

Hepatitis B Diagnostic Tests Market: Report Scope

Hepatitis B Diagnostic Tests Market Segmentation Analysis

The study provides a decisive view of the hepatitis B diagnostic tests market by segmenting the market based on product type, end user, and regions.

The global hepatitis B diagnostic tests market is segmented into product type, end user, and geography.

Based on the product type the hepatitis B diagnostic tests market is segmented as a point of care testing kits and enzyme immunoassay kits. The point-of-care testing kits segment is sub-segmented into strips and cards/cassettes.

By end user, the global hepatitis B diagnostic tests market is segmented into hospitals, diagnostic centers, clinics, and home care settings. The enzyme immunoassay kits segment is further segmented as anti-hepatitis B core antibody test, hepatitis B surface antigen test, and anti-hepatitis B surface antibody test.

Hepatitis B Diagnostic Tests Market Regional Analysis

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further division into major countries including the U.S., Rest of North America, the UK, Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, Brazil, Rest of Latin America, GCC Countries, South Africa, and Rest of the Middle East and Africa. This segmentation includes demand for hepatitis B diagnostic tests market based on individual product type and end-user in all the regions and countries.

The report also includes detailed profiles of end players such as

• Bio-Rad Laboratories, Inc.
• bioMérieux SA
• Abbott Laboratories
• Biogate Laboratories Ltd.
• DiaSorin S.p.A.
• Vista Diagnostics International
• Meridian Bioscience, Inc.
• J.Mitra & Co. Ltd.
• General Biologicals Corporation
• and Siemens Medical Solutions USA, Inc.

This report segments the global Hepatitis B Diagnostic Tests market as follows:

By Product Type 

• Enzyme Immunoassay Kits 
  • Anti-hepatitis B core antibody test
  • Hepatitis B surface antigen test 
  • Anti-hepatitis B surface antibody test 
• Point-of-care Testing Kits 
  • Strips 
  • Cassettes/Cards 

By End-User 

• Hospitals
• Diagnostic Centers
• Clinics
• Home Care

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America